Genescience Pharmaceuticals Co., Ltd.

1. Wall Street Reporter Interviews Dr. Lei Jin, Founder and CEO of GenSci
12-05-2006

SHANGHAI, China- Dec 5, 2006-Dr. Lei Jin, Founder and CEO of GeneScience Pharmaceuticals Co., Ltd. (GenSci) was interviewed by Wall Street Reporter on December 4, 2006. Dr. Jin briefly int roduced his company, aiming at a potential market size of $2 billion with 6 core products, which has enjoyed a tremendous growth since the company was founded 10 ...

2. GenSci Expects Topical Molgramostim Gel Approval in 2007
11-03-2006

SHANGHAI, China--(BUSINESS WIRE)--GeneScience Pharmaceuticals Co., Ltd. (GenSci) announced today that the company's new drug, Genfulin™, a topical gel indicated for the treatment of wound healing, is expected to get approval by China's SFDA in early 2007. The active ingredient in Genfulin™ is molgramostim (human granulocyte-macrophage colony stimulating ...